Arcutis Biotherapeutics (ARQT) Earnings Date & Reports

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ARQT is expected to report earnings to fall 147.22% to 4 cents per share on July 30

Arcutis Biotherapeutics ARQT Stock Earnings Reports

Q2'26

Est.

$0.04

Q1'26

Missed

by $0.04

Q4'25

Beat

by $0.05

Q3'25

Beat

by $0.15

Q2'25

Beat

by $0.04

The last earnings report on May 06 showed earnings per share of -9 cents, missing the estimate of -5 cents. With 1.33M shares outstanding, the current market capitalization sits at 3.05B.

View a ticker or compare two or three

Compare

ARQT

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ARQT